Most transgender adolescents receiving a gonadotropin-releasing hormone agonist combined with gender-confirming hormone therapy grow to an adult height close to the reference height for their sex assigned at birth, according to study data.
“Our study provides evidence that Danish transgender adolescents starting gender-affirming HT before the age of 18 years reach a normal adult height for
AUSTIN, Texas, April 18, 2024 Lumos Pharma, Inc. , a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency through Phase 2 clinical trials,.